Clinical trials
Phase 1/2 Multiple Myeloma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
| Terminated | 8 |
| Active, not recruiting | 6 |
| Completed | 6 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Hoffmann-La Roche | 3 |
| AbbVie | 2 |
| AstraZeneca | 2 |
| Celgene | 2 |
| Novartis Pharmaceuticals | 2 |
| Peter MacCallum Cancer Centre, Australia | 2 |
| Regeneron Pharmaceuticals | 2 |
| Accenture | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 32 |
| Recurrence | 8 |
| Hematologic Neoplasms | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma | 2 |
| Neoplasms | 2 |
| Hodgkin Disease | 1 |
| Leukemia | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.